Invida Pharmaceutical Holdings to Market Three Dermatology Products in China

Bookmark and Share

ChinaBio Today -- Invida Group of Singapore announced plans to launch three dermatological brands in China: Dermatix®, Zalain® and Kinerase®. Invida, though mainly a commercialization company, also has proprietary products. With 13 subsidiaries and more than 3,700 employees, Invida was established as a Joint Venture in 2005 by Temasek Holdings, Quintiles Transnational and the Zuellig Group. Earlier entities have been providing commercialization services in Asia Pacific for more than 50 years. More details...

MORE ON THIS TOPIC